Lionsgate Studios Corp Common Shares vs Nutrien Ltd — how do they compare? Lionsgate Studios Corp Common Shares trades at $10.86 (market cap $3.31B), while Nutrien Ltd trades at $69.87 (market cap $33.13B). The key difference: Nutrien Ltd is far larger — about 10× Lionsgate Studios Corp Common Shares's market cap, and Nutrien Ltd pays a 3.16% dividend while Lionsgate Studios Corp Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lionsgate Studios Corp Common Shares for 0 Days and Nutrien Ltd for 60 Days on average.
| LION | NTR | |
|---|---|---|
Market Cap | $3.31B | $33.13B |
Volume | 2,146,134 | 2,165,412 |
Sector | Technology | Basic Materials |
52-Week High | $16.40 | $83.94 |
52-Week Low | $5.91 | $53.64 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $6.82B | $44.94B |
Dividend Yield | — | 3.16% |
Signals from Pluang's Aura AI — not financial advice
LION trades at $11.12, up 0.36% on the day, with a market cap of approximately $1.3 billion. The stock shows mixed signals: strong analyst support (87.5% buy rating) and a consensus price target of $16.80 suggest upside, but negative net income and shareholder equity highlight financial strain. Recent Q1 2027 earnings beat estimates with EPS of $0.37, yet the company remains unprofitable with a net loss of $128.5 million in 2025. Takeover interest from firms like Bolloré adds speculative appeal.
The outlook hinges on operational turnaround and potential M&A. Revenue growth from hit films like 'Michael' and a valuable content library offer catalysts, but high debt ($3.65B total) and consistent losses pose significant risks. Investors should weigh the 51% upside to price targets against fundamental weaknesses and industry volatility.
Nutrien (NTR) trades at $69.68, up 2.47% with mixed technical signals showing bearish momentum but oversold conditions. The company reported Q2 2026 earnings miss ($2.61 vs $2.70 expected) but maintains stable revenue growth projections. Strong institutional interest continues with BlackRock acquiring a $220 million position in Q2 2026, while analyst consensus remains positive with a $77.29 price target representing 11% upside potential.
The fertilizer producer faces near-term headwinds from potential Belarus potash imports but benefits from structural North American gas advantages. While technical indicators suggest caution, fundamental valuation metrics (P/E 14.11, P/S 1.19) appear reasonable given the company's market leadership position and improving profitability trends from 2024 lows.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Lionsgate Studios Corp. is a standalone content company that develops, finances, produces, and distributes motion pictures and television series, licensing its content to theaters, streaming platforms, television networks, and home entertainment channels.
Read more on LION →Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →